SINOPHARM(CNCM LTD)

600511
28.380.11% ( -0.03 )
Delay Closed: Nov 13, 15:00:00

Valuation

Current ValuationThe current P/E ratio is 10.81, within the reasonable range, cheaper than 72.91% of the time in the past 5 years, and the industry ranks 4/27, the industry Median 12.74.

10.81xP/E
Stock price¥28.38Earnings per share¥2.63

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 12.74x
0481216

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 12.74x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
601607SHShanghai Pharma
11.58x5.26%¥59.82B
000963SZHUADONG MEDICINE
13.22x1.36%¥45.44B
600332SHGYBYS
14.53x17.74%¥31.46B
600998SHJointown
13.08x2.27%¥25.67B
600511SHSINOPHARM(CNCM LTD)
10.81x5.06%¥21.41B
200028SZSinopharm Accord
5.89x--¥7.84B
000028SZSinopharm Accord
11.26x8.67%¥12.73B
600211SHTIBET PHARMA
12.74x--¥12.64B
600713SHNPGC
10.66x--¥6.80B
603368SHGUANGXI LIUYAO GROUP
10.42x4.47%¥6.47B
000411SZINT'L GROUP
11.27x--¥5.39B
002788SZLUYAN PHARMA
13.24x--¥3.62B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.